Anders Angelsen
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Prostate Cancer Diagnosis and Treatment 16
- Prostate Cancer Treatment and Research 10
-
- Metabolomics and Mass Spectrometry Studies 4
- Molecular Biology Techniques and Applications 2
- Co-authors
- Arne Solberg (8 shared papers)Olbjørn Klepp (5 shared papers)May‐Britt Tessem (12 shared papers)Anders Widmark (5 shared papers)Helena Bertilsson (12 shared papers)Fredrik Wiklund (3 shared papers)Morten Høyer (2 shared papers)J.‐E. Damber (2 shared papers)
In The Last Decade
Anders Angelsen
44 papers receiving 2.1k citations
Anders Angelsen's Hit Papers
Peers
Comparison fields: 5 of 88
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 249
- Urology 89
- Rheumatology 172
- Radiation 79
Countries citing papers authored by Anders Angelsen
This map shows the geographic impact of Anders Angelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Angelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Angelsen more than expected).
Fields of papers citing papers by Anders Angelsen
This network shows the impact of papers produced by Anders Angelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Angelsen. The network helps show where Anders Angelsen may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Angelsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial Hit paper breakdown → | 2008 | 623 |
| 2 | 2013 | 159 | |
| 3 | 2008 | 110 | |
| 4 | 1997 | 105 | |
| 5 | 2003 | 92 | |
| 6 | 2015 | 83 | |
| 7 | 2012 | 68 | |
| 8 | 2012 | 62 | |
| 9 | 2014 | 60 | |
| 10 | 2016 | 58 | |
| 11 | 1997 | 51 | |
| 12 | 2008 | 49 | |
| 13 | 2018 | 46 | |
| 14 | 2012 | 43 | |
| 15 | 2007 | 43 | |
| 16 | 2010 | 40 | |
| 17 | 2012 | 34 | |
| 18 | 2001 | 33 | |
| 19 | 2014 | 31 | |
| 20 | 2018 | 31 |
About Anders Angelsen
Anders Angelsen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (10 papers), Cancer, Lipids, and Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (4 papers), MRI in cancer diagnosis (2 papers), Urinary Bladder and Prostate Research (2 papers), Molecular Biology Techniques and Applications (2 papers) and Testicular diseases and treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (249 citations), Urology (89 citations), Rheumatology (172 citations) and Radiation (79 citations). Anders Angelsen has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Arne Solberg, Olbjørn Klepp, May‐Britt Tessem, Anders Widmark, Helena Bertilsson, Fredrik Wiklund, Morten Høyer, J.‐E. Damber, Trond Viset and Sophie D. Fosså. Their work appears in journals such as The Prostate, Journal of Clinical Oncology, European Urology, PLoS ONE and BMC Medical Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.